Tradewinds Capital Management LLC reduced its position in Express Scripts Holding Co (NASDAQ:ESRX) by 15.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,148 shares of the company’s stock after selling 2,158 shares during the period. Tradewinds Capital Management LLC’s holdings in Express Scripts were worth $1,154,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of ESRX. Landaas & Co. WI ADV acquired a new position in Express Scripts in the 2nd quarter worth about $102,000. Kaizen Advisory LLC increased its position in Express Scripts by 147.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after purchasing an additional 800 shares during the last quarter. Adviser Investments LLC increased its position in Express Scripts by 321.9% in the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after purchasing an additional 1,130 shares during the last quarter. TRUE Private Wealth Advisors acquired a new position in Express Scripts in the 3rd quarter worth about $115,000. Finally, Sun Life Financial INC increased its position in Express Scripts by 758.8% in the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after purchasing an additional 1,343 shares during the last quarter. 84.74% of the stock is currently owned by institutional investors.
In other news, insider Christine Houston sold 12,898 shares of the stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.79% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, topping the Zacks’ consensus estimate of $2.42 by $0.01. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company had revenue of $25.56 billion during the quarter, compared to the consensus estimate of $25.11 billion. During the same quarter last year, the company earned $2.51 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. On average, equities research analysts forecast that Express Scripts Holding Co will post 9.07 EPS for the current year.
Several analysts have recently issued reports on ESRX shares. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and upped their price target for the stock from $90.00 to $96.50 in a research note on Tuesday, September 18th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Royal Bank of Canada upped their price target on Express Scripts to $94.00 and gave the stock an “outperform” rating in a research note on Monday, August 27th. Finally, Robert W. Baird downgraded Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price target for the company. in a research note on Friday, July 20th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $87.79.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Further Reading: What is a bull market?
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.